Publications by authors named "Blessy Antony"

Background: The cause and symptoms of long COVID are poorly understood. It is challenging to predict whether a given COVID-19 patient will develop long COVID in the future.

Methods: We used electronic health record (EHR) data from the National COVID Cohort Collaborative to predict the incidence of long COVID.

View Article and Find Full Text PDF

The rapid growth of online social media usage in our daily lives has increased the importance of analyzing the dynamics of online social networks. However, the dynamic data of existing online social media platforms are not readily accessible. Hence, there is a necessity to synthesize networks emulating those of online social media for further study.

View Article and Find Full Text PDF

Background: Stratification of patients with post-acute sequelae of SARS-CoV-2 infection (PASC, or long COVID) would allow precision clinical management strategies. However, long COVID is incompletely understood and characterised by a wide range of manifestations that are difficult to analyse computationally. Additionally, the generalisability of machine learning classification of COVID-19 clinical outcomes has rarely been tested.

View Article and Find Full Text PDF
Article Synopsis
  • * They analyzed electronic health records from 52 hospitals and found that metformin significantly reduced the incidence of severe COVID-19 compared to other treatments in those with prediabetes.
  • * While metformin showed some benefits for COVID-19 severity in patients with PCOS, the results were not as strong compared to those in the prediabetes group, highlighting metformin's potential benefits for different conditions.
View Article and Find Full Text PDF

Accurate stratification of patients with post-acute sequelae of SARS-CoV-2 infection (PASC, or long COVID) would allow precision clinical management strategies. However, the natural history of long COVID is incompletely understood and characterized by an extremely wide range of manifestations that are difficult to analyze computationally. In addition, the generalizability of machine learning classification of COVID-19 clinical outcomes has rarely been tested.

View Article and Find Full Text PDF